Patient Guide: Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 22 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07190222
Status: 🟢 Enrolling Now
Condition: Chronic Obstructive Pulmonary Disease
Phase: PHASE3

Where You Can Participate

This study is available at 22 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Lakewood, Colorado
  • • Greenacres City, Florida
  • • And 19 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype - Join Clinical Trial NCTNCT07190222

How to Join This Clinical Trial - NCTNCT07190222

Learn how to participate in this PHASE3 trial studying an investigational therapy for Chronic Obstructive Pulmonary Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Obstructive Pulmonary Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Obstructive Pulmonary Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07190222 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 22 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85712 - United States

Status: RECRUITING

Clinical Research Site

Lakewood, Colorado 80228 - United States

Status: RECRUITING

Clinical Research Site

Greenacres City, Florida 33467 - United States

Status: RECRUITING

Clinical Research Site

Loxahatchee Groves, Florida 33470 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33186 - United States

Status: RECRUITING

Clinical Research Site

Orlando, Florida 32825 - United States

Status: RECRUITING

Clinical Research Site

Adairsville, Georgia 30103 - United States

Status: RECRUITING

Clinical Research Site

Shreveport, Louisiana 71105 - United States

Status: RECRUITING

Clinical Research Site

New Bedford, Massachusetts 02740 - United States

Status: RECRUITING

Clinical Research Site

Brighton, Michigan 48116 - United States

Status: RECRUITING

And 12 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Chronic Obstructive Pulmonary Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships